Identification (see Thin-Layer Chromatographic Identification Test 201)
Adsorbent:
chromatographic silica gel.
Developing solvent:
mixture of chloroform and diethylamine (9:1).
Test preparation
Use undiluted. Apply 15 µL.
Detection reagent:
potassium iodoplatinate TS.
Assay
Acetate buffer
Prepare a solution in water containing in each L 0.05 mole of sodium acetate and 2.9 mL of glacial acetic acid.
Mobile phase
Transfer 5.1 g of tetrabutylammonium hydrogen sulfate to a 1-L volumetric flask, add 50 mL of acetonitrile, and dilute with Acetate buffer to volume. Adjust with 5 N sodium hydroxide to a pH of 5.5 ± 0.1.
Standard preparation
Dissolve an accurately weighed quantity of
USP Atropine Sulfate RS in water, and dilute quantitatively with water to obtain a solution having a known concentration of about 80 µg per mL.
Assay preparation
Transfer an accurately measured volume of Injection, equivalent to about 2 mg of atropine sulfate, to a 25-mL volumetric flask, dilute with water to volume, and mix.
Resolution solution
Prepare a solution in water containing about 2.5 µg of p-hydroxybenzoic acid per mL. Dilute one volume of this solution with four volumes of the Standard preparation.
Chromatographic system (see Chromatography 621)
The liquid chromatograph is equipped with a 254-nm detector and 30-cm × 3.9-mm column that contains packing L1. The flow rate is about 2 mL per minute. Chromatograph the
Standard preparation, and record the peak responses as directed for
Procedure: the relative standard deviation for replicate injections is not more than 1.5%. In a similar manner, chromatograph the
Resolution solution: the retention time of
p-hydroxybenzoic acid is about 1.6 relative to that of atropine, and the resolution,
R, between the
p-hydroxybenzoic acid and atropine peaks is not less than 2.2.
Procedure
Separately inject equal volumes (about 100 µL) of the
Standard preparation and the
Assay preparation into the chromatograph, record the chromatograms, and measure the areas for the major peaks. Calculate the quantity, in mg, of (C
17H
23NO
3)
2·H
2SO
4·H
2O in each mL of the Injection taken by the formula:
(694.85/676.83)(25C/V)(rU / rS),
in which 694.85 and 676.83 are the molecular weights of atropine sulfate monohydrate and anhydrous atropine sulfate, respectively;
C is the concentration, in mg per mL, of
USP Atropine Sulfate RS in the
Standard preparation; V is the volume, in mL, of Injection taken; and
rU and
rS are the peak responses obtained from the
Assay preparation and the
Standard preparation, respectively.